Variations in apolipoprotein D and sigma non-opioid intracellular receptor 1 genes with relation to risk, severity and outcome of ischemic stroke

BMC Neurology

Volumn 14, Issue 1, 2014, Pages

  Lövkvist, Håkan ^a,b   Jönsson, Ann Cathrin ^c   Luthman, Holger ^d   Jood, Katarina ^e   Jern, Christina ^e   Wieloch, Tadeusz ^c   Lindgren, Arne ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d LUND UNIVERSITY   (Sweden)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

APOD; Genetics; mRS; NIHSS; SIGMAR1; Stroke

Indexed keywords

APOLIPOPROTEIN D; SIGMA NON OPIOID INTRACELLULAR RECEPTOR 1; SIGMA OPIATE RECEPTOR; UNCLASSIFIED DRUG; SIGMA-1 RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PHENOTYPE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE PATIENT; ADOLESCENT; CONVALESCENCE; GENETICS; MIDDLE AGED; REGISTER; RISK; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; STROKE; SWEDEN; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS D; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, SIGMA; RECOVERY OF FUNCTION; REGISTRIES; RISK; SEVERITY OF ILLNESS INDEX; STROKE; SWEDEN; YOUNG ADULT;

EID: 84908082268     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/s12883-014-0191-2     Document Type: Article

References (54)

1. Luengo-Fernandez R, Paul NL, Gray AM, Pendlebury ST, Bull LM, Welch SJ, Cuthbertson FC, Rothwell PM. Population-based study of disability and institutionalization after transient ischemic attack and stroke: 10-year results of the Oxford Vascular Study. Stroke 2013, 44(10):2854-2861. 10.1161/STROKEAHA.113.001584, 23920019.
2. McNaughton H, Feigin V, Kerse N, Barber PA, Weatherall M, Bennett D, Carter K, Hackett M, Anderson C. Ethnicity and functional outcome after stroke. Stroke 2011, 42(4):960-964. 10.1161/STROKEAHA.110.605139, 21311061.
3. Feigin VL, Barker-Collo S, Parag V, Senior H, Lawes CM, Ratnasabapathy Y, Glen E. Auckland Stroke Outcomes Study. Part 1: Gender, stroke types, ethnicity, and functional outcomes 5 years poststroke. Neurology 2010, 75(18):1597-1607. 10.1212/WNL.0b013e3181fb44b3, 21041783.
4. Rensink M, Schuurmans M, Lindeman E, Hafsteinsdottir T. Task-oriented training in rehabilitation after stroke: systematic review. J Adv Nurs 2009, 65(4):737-754. 10.1111/j.1365-2648.2008.04925.x, 19228241.
5. Brogårdh C, Lexell J. Effects of cardiorespiratory fitness and muscle-resistance training after stroke. PM R 2012, 4(11):901-907. 10.1016/j.pmrj.2012.09.1157, 23174557.
6. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, Creager MA, Culebras A, Eckel RH, Hart RG, Hinchey JA, Howard VJ, Jauch EC, Levine SR, Meschia JF, Moore WS, Nixon JV, Pearson TA. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42(2):517-584. 10.1161/STR.0b013e3181fcb238, 21127304.
7. Endres M, Engelhardt B, Koistinaho J, Lindvall O, Meairs S, Mohr JP, Planas A, Rothwell N, Schwaninger M, Schwab ME, Vivien D, Wieloch T, Dirnagl U. Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc Dis 2008, 25(3):268-278. 10.1159/000118039, 18292653.
8. Pekna M, Pekny M. The neurobiology of brain injury. Cerebrum 2012, 2012:9. 23447795.
9. Wieloch T, Nikolich K. Mechanisms of neural plasticity following brain injury. Curr Opin Neurobiol 2006, 16(3):258-264. 10.1016/j.conb.2006.05.011, 16713245.
10. Cramer SC, Procaccio V. Correlation between genetic polymorphisms and stroke recovery: analysis of the GAIN Americas and GAIN International Studies. Eur J Neurol 2012, 19(5):718-724. 10.1111/j.1468-1331.2011.03615.x, 22221491.
11. Lövkvist H, Smith JG, Luthman H, Höglund P, Norrving B, Kristoffersson U, Jönsson AC, Lindgren AG. Ischaemic stroke in hypertensive patients is associated with variations in the PDE4D genome region. Eur J Hum Genet 2008, 16(9):1117-1125. 10.1038/ejhg.2008.62, 18398440.
12. Smith JG, Melander O, Lövkvist H, Hedblad B, Engström G, Nilsson P, Carlson J, Berglund G, Norrving B, Lindgren A. Common genetic variants on chromosome 9p21 confers risk of ischemic stroke: a large-scale genetic association study. Circ Cardiovasc Genet 2009, 2(2):159-164. 10.1161/CIRCGENETICS.108.835173, 20031580.
13. Williams FM, Carter AM, Hysi AM, Surdulescu G, Hodgkiss D, Soranzo N, Traylor M, Bevan S, Dichgans M, Rothwell PM. Ischemic stroke is associated with AB0 locus: The Euroclot study. Ann Neurol 2012, 73(1):16-31. 10.1002/ana.23838.
14. Bellenguez C, Bevan S, Gschwendtner A, Spencer CC, Burgess AI, Pirinen M, Jackson CA, Traylor M, Strange A, Su Z, Band G, Syme PD, Malik R, Pera J, Norrving B, Lemmens R, Freeman C, Schanz R, James T, Poole D, Murphy L, Segal H, Cortellini L, Cheng YC, Woo D, Nalls MA, Müller-Myhsok B, Meisinger C, Seedorf U, Ross-Adams H, et al. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet 2012, 44(3):328-333. 10.1038/ng.1081, 22306652.
15. Gschwendtner A, Bevan S, Cole JW, Plourde A, Matarin M, Ross-Adams H, Meitinger T, Wichmann E, Mitchell BD, Furie K, Slowik A, Rich SS, Syme PD, MacLeod MJ, Meschia JF, Rosand J, Kittner SJ, Markus HS, Müller-Myhsok B, Dichgans M. Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann Neurol 2009, 65(5):531-539. 10.1002/ana.21590, 19475673.
16. Holliday EG, Maguire JM, Evans TJ, Koblar SA, Jannes J, Sturm JW, Hankey GJ, Baker R, Golledge J, Parsons MW, Malik R, McEvoy M, Biros E, Lewis MD, Lincz LF, Peel R, Oldmeadow C, Smith W, Moscato P, Barlera S, Bevan S, Bis JC, Boerwinkle E, Boncoraglio GB, Brott TG, Brown RD, Cheng YC, Cole JW, Cotlarciuc I, Devan WJ, et al. Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat Genet 2012, 44(10):1147-1151. 10.1038/ng.2397, 22941190.
17. Traylor M, Farrall M, Holliday EG, Sudlow C, Hopewell JC, Cheng YC, Fornage M, Ikram MA, Malik R, Bevan S, Thorsteinsdottir U, Nalls MA, Longstreth W, Wiggins KL, Yadav S, Parati EA, Destefano AL, Worrall BB, Kittner SJ, Khan MS, Reiner AP, Helgadottir A, Achterberg S, Fernandez-Cadenas I, Abboud S, Schmidt R, Walters M, Chen WM, Ringelstein EB, O'Donnell M, et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol 2012, 11(11):951-962. 10.1016/S1474-4422(12)70234-X, 23041239.
18. Gretarsdottir S, Thorleifsson G, Manolescu A, Styrkarsdottir U, Helgadottir A, Gschwendtner A, Kostulas K, Kuhlenbäumer G, Bevan S, Jonsdottir T, Bjarnason H, Saemundsdottir J, Palsson S, Arnar DO, Holm H, Thorgeirsson G, Valdimarsson EM, Sveinbjörnsdottir S, Gieger C, Berger K, Wichmann HE, Hillert J, Markus H, Gulcher JR, Ringelstein EB, Kong A, Dichgans M, Gudbjartsson DF, Thorsteinsdottir U, Stefansson K. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Ann Neurol 2008, 64(4):402-409. 10.1002/ana.21480, 18991354.
19. Gudbjartsson DF, Holm H, Gretarsdottir S, Thorleifsson G, Walters GB, Thorgeirsson G, Gulcher J, Mathiesen EB, Njølstad I, Nyrnes A, Wilsgaard T, Hald EM, Hveem K, Stoltenberg C, Kucera G, Stubblefield T, Carter S, Roden D, Ng MC, Baum L, So WY, Wong KS, Chan JC, Gieger C, Wichmann HE, Gschwendtner A, Dichgans M, Kuhlenbäumer G, Berger K, Ringelstein EB, et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet 2009, 41(8):876-878. 10.1038/ng.417, 19597491.
20. Biffi A, Anderson CD, Jagiella JM, Schmidt H, Kissela B, Hansen BM, Jimenez-Conde J, Pires CR, Ayres AM, Schwab K, Cortellini L, Pera J, Urbanik A, Romero JM, Rost NS, Goldstein JN, Viswanathan A, Pichler A, Enzinger C, Rabionet R, Norrving B, Tirschwell DL, Selim M, Brown DL, Silliman SL, Worrall BB, Meschia JF, Kidwell CS, Broderick JP, Greenberg SM, et al. APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study. Lancet Neurol 2011, 10(8):702-709. 10.1016/S1474-4422(11)70148-X, 21741316.
21. Maguire J, Thakkinstian A, Levi C, Lincz L, Bisset L, Sturm J, Scott R, Whyte S, Attia J. Impact of COX-2 rs5275 and rs20417 and GPIIIa rs5918 polymorphisms on 90-day ischemic stroke functional outcome: a novel finding. J Stroke Cerebrovasc Dis 2011, 20(2):134-144. 10.1016/j.jstrokecerebrovasdis.2009.10.011, 20472470.
22. Pearson-Fuhrhop KM, Minton B, Acevedo D, Shahbaba B, Cramer SC. Genetic variation in the human brain dopamine system influences motor learning and its modulation by L-Dopa. PLoS One 2013, 8(4):e61197. 10.1371/journal.pone.0061197, 23613810.
23. Elliott DA, Weickert CS, Garner B. Apolipoproteins in the brain: implications for neurological and psychiatric disorders. Clin Lipidol 2010, 51(4):555-573. 10.2217/clp.10.37, 21423873.
24. Rassart E, Bedirian A, Do Carmo S, Guinard O, Sirois J, Terrisse L, Milne R. Apolipoprotein D. Biochim Biophys Acta 2000, 1482(1-2):185-198. 10.1016/S0167-4838(00)00162-X, 11058760.
25. Ordonez C, Navarro A, Perez C, Martinez E, del Valle E, Tolivia J. Gender differences in apolipoprotein D expression during aging and in Alzheimer disease. Neurobiol Aging 2012, 33(2):433 e411-420.
26. Thomas EA, Dean B, Pavey G, Sutcliffe JG. Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders. Proc Natl Acad Sci U S A 2001, 98(7):4066-4071. 10.1073/pnas.071056198, 11274430.
27. Belloir B, Kovari E, Surini-Demiri M, Savioz A. Altered apolipoprotein D expression in the brain of patients with Alzheimer disease. J Neurosci Res 2001, 64(1):61-69. 10.1002/jnr.1054, 11276052.
28. Shibata N, Nagata T, Shinagawa S, Ohnuma T, Shimazaki H, Komatsu M, Kuerban B, Tomson K, Nakayama K, Yamada H, Arai H. Genetic association between APOA1 and APOD polymorphisms and Alzheimer's disease in a Japanese population. J Neural Transm 2013, 120(11):1599-1603. 10.1007/s00702-013-1036-7, 23690001.
29. Ordonez C, Navarro A, Perez C, Astudillo A, Martinez E, Tolivia J. Apolipoprotein D expression in substantia nigra of Parkinson disease. Histol Histopathol 2006, 21(4):361-366. 16437381.
30. Navarro A, Alonso A, Garrido P, Gonzalez C, Gonzalez Del Rey C, Ordonez C, Tolivia J. Increase in placental apolipoprotein D as an adaptation to human gestational diabetes. Placenta 2010, 31(1):25-31. 10.1016/j.placenta.2009.11.002, 19944460.
31. Rickhag M, Deierborg T, Patel S, Ruscher K, Wieloch T. Apolipoprotein D is elevated in oligodendrocytes in the peri-infarct region after experimental stroke: influence of enriched environment. J Cereb Blood Flow Metab 2008, 28(3):551-562. 10.1038/sj.jcbfm.9600552, 17851453.
32. Franz G, Reindl M, Patel SC, Beer R, Unterrichter I, Berger T, Schmutzhard E, Poewe W, Kampfl A. Increased expression of apolipoprotein D following experimental traumatic brain injury. J Neurochem 1999, 73(4):1615-1625. 10.1046/j.1471-4159.1999.0731615.x, 10501208.
33. Chen Y, Jia L, Wei C, Wang F, Lv H, Jia J. Association between polymorphisms in the apolipoprotein D gene and sporadic Alzheimer's disease. Brain Res 2008, 1233:196-202. 10.1016/j.brainres.2008.07.018, 18671953.
34. Ganfornina MD, Do Carmo S, Lora JM, Torres-Schumann S, Vogel M, Allhorn M, Gonzalez C, Bastiani MJ, Rassart E, Sanchez D. Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress. Aging Cell 2008, 7(4):506-515. 10.1111/j.1474-9726.2008.00395.x, 18419796.
35. Bhatia S, Knoch B, Wong J, Kim WS, Else PL, Oakley AJ, Garner B. Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein D: implications for lipid antioxidant activity and Alzheimer's disease. Biochemical J 2012, 442(3):713-721. 10.1042/BJ20111166.
36. Kourrich S, Su TP, Fujimoto M, Bonci A. The sigma-1 receptor: roles in neuronal plasticity and disease. Trends Neurosci 2012, 35(12):762-771. 10.1016/j.tins.2012.09.007, 23102998.
37. Ruscher K, Shamloo M, Rickhag M, Ladunga I, Soriano L, Gisselsson L, Toresson H, Ruslim-Litrus L, Oksenberg D, Urfer R, Johansson BB, Nikolich K, Wieloch T. The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke. Brain 2011, 134(3):732-746. 10.1093/brain/awq367, 21278085.
38. Kishi T, Yoshimura R, Okochi T, Fukuo Y, Kitajima T, Okumura T, Tsunoka T, Kawashima K, Yamanouchi Y, Kinoshita Y, Umene-Nakano W, Naitoh H, Nakamura J, Ozaki N, Iwata N. Association analysis of SIGMAR1 with major depressive disorder and SSRI response. Neuropharmacology 2010, 58(7):1168-1173. 10.1016/j.neuropharm.2010.02.013, 20178807.
39. Ishiguro H, Ohtsuki T, Toru M, Itokawa M, Aoki J, Shibuya H, Kurumaji A, Okubo Y, Iwawaki A, Ota K, Shimizu H, Hamaguchi H, Arinami T. Association between polymorphisms in the type 1 sigma receptor gene and schizophrenia. Neurosci Lett 1998, 257(1):45-48. 10.1016/S0304-3940(98)00797-6, 9857962.
40. Miyatake R, Furukawa A, Matsushita S, Higuchi S, Suwaki H. Functional polymorphisms in the sigma1 receptor gene associated with alcoholism. Biol Psychiatry 2004, 55(1):85-90. 10.1016/j.biopsych.2003.07.008, 14706429.
41. Feher A, Juhasz A, Laszlo A, Kalman J, Pakaski M, Kalman J, Janka Z. Association between a variant of the sigma-1 receptor gene and Alzheimer's disease. Neurosci Lett 2012, 517(2):136-139. 10.1016/j.neulet.2012.04.046, 22561649.
42. Hallström B, Jönsson AC, Nerbrand C, Petersen B, Norrving B, Lindgren A. Lund Stroke Register: hospitalization pattern and yield of different screening methods for first-ever stroke. Acta Neurol Scand 2007, 115(1):49-54. 10.1111/j.1600-0404.2006.00738.x, 17156265.
43. Jood K, Ladenvall C, Rosengren A, Blomstrand C, Jern C. Family history in ischemic stroke before 70 years of age: the Sahlgrenska Academy Study on Ischemic Stroke. Stroke 2005, 36(7):1383-1387. 10.1161/01.STR.0000169944.46025.09, 15933254.
44. Goldstein LB, Bertels C, Davis JN. Interrater reliability of the NIH stroke scale. Arch Neurol 1989, 46(6):660-662. 10.1001/archneur.1989.00520420080026, 2730378.
45. Multicenter trial of hemodilution in ischemic stroke--background and study protocol. Scandinavian Stroke Study Group. Stroke 1985, 16(5):885-890.
46. Gray LJ, Ali M, Lyden PD, Bath PM. Interconversion of the National Institutes of Health Stroke Scale and Scandinavian Stroke Scale in acute stroke. J Stroke Cerebrovasc Dis 2009, 18(6):466-468. 10.1016/j.jstrokecerebrovasdis.2009.02.003, 19900650.
47. Adams HP, Bendixen BH, Leira E, Chang KC, Davis PH, Woolson RF, Clarke WR, Hansen MD. Antithrombotic treatment of ischemic stroke among patients with occlusion or severe stenosis of the internal carotid artery: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999, 53(1):122-125. 10.1212/WNL.53.1.122, 10408547.
48. Eriksson M, Appelros P, Norrving B, Terent A, Stegmayr B. Assessment of functional outcome in a national quality register for acute stroke: can simple self-reported items be transformed into the modified Rankin Scale?. Stroke 2007, 38(4):1384-1386. 10.1161/01.STR.0000260102.97954.9c, 17322093.
49. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988, 19(5):604-607. 10.1161/01.STR.19.5.604, 3363593.
50. Olsson S, Jood K, Blomstrand C, Jern C. Genetic variation on chromosome 9p21 shows association with the ischaemic stroke subtype large-vessel disease in a Swedish sample aged
51. Starby H, Delavaran H, Andsberg G, Lövkvist H, Norrving B, Lindgren A. Multiplicity of risk factors in ischemic stroke patients: relations to age, sex, and subtype - a study of 2,505 patients from the Lund Stroke Register. Neuroepidemiology 2014, 42(3):161-168. 10.1159/000357150, 24556909.
52. Flossmann E, Schulz UG, Rothwell PM. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 2004, 35(1):212-227. 10.1161/01.STR.0000107187.84390.AA, 14684773.
53. Schutze MP, Peterson PA, Jackson MR. An N-terminal double-arginine motif maintains type II membrane proteins in the endoplasmic reticulum. EMBO J 1994, 13(7):1696-1705. 8157008.
54. Hansen T, Hemmingsen RP, Wang AG, Olsen L, Timm S, Soeby K, Jakobsen KD, Fenger M, Parnas J, Rasmussen HB, Werge T. Apolipoprotein D is associated with long-term outcome in patients with schizophrenia. Pharmacogenomics J 2006, 6(2):120-125. 10.1038/sj.tpj.6500350, 16402085.